Derms on Drugs
autor: Scholars in Medicine
Nejnovější epizoda
Better Croissants, Stranger Drugs
Better Croissants, Stranger Drugs
O tomto podcastu
Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology.
It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful.
Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for healthcare professionals of all levels of experience and education.
Epizody
Nejnovějších 20 z 93 epizod
- Better Croissants, Stranger Drugs · 34 min · Řada 4 Epizoda 87EADV serves up better croissants—and a packed menu of new mechanisms. The Derms dig into injectable RNA for BCC, a possible anti-scarring angle in HS, a TYK2 showdown, and an…
- The Fast and the Urticarious · 24 minDr. Jason Hawkes makes the case for putting speed first when choosing an advanced treatment for CSU. Remibrutinib works fast—but can he convince the Derms that fast is reason…
- High D, Low Certainty · 32 min · Řada 4 Epizoda 86The Derms size up high-dose vitamin D, a head-to-head lichen planus trial, and whether contact dermatitis testing is overcalling the culprit.
- Custom Shots and Drug Cocktails · 29 min · Řada 4 Epizoda 85The Derms question treatment monogamy: a personalized melanoma vaccine joins forces with immunotherapy, while dual therapy takes on refractory HS and AD.
- AI Crosses the Prescription Line · 37 min · Řada 4 Epizoda 84In Utah, AI is getting its hands on the prescription pad—starting with topical acne treatment. The Derms grill Nolla’s CEO on the big questions: Who catches the misses, and is…
- The Goldilocks Biologic · 16 minDr. Steve Daveluy makes the case that Cosentyx is the “just right” first biologic for HS—but not every Derm is ready to move past TNFs. Durability, infection risk, IBD, and…
- Tiny Vesicles, Big Claims · 37 min · Řada 4 Epizoda 83Exosomes may be real science, but the marketing has sprinted miles ahead of the data. The Derms dig into their promise for burns and epidermolysis bullosa—and why that pricey…
- Cuts, Switches, and Eight Extra Hairs · 28 min · Řada 4 Epizoda 82Three papers, three practical questions: Who really needs antibiotics before derm surgery? What comes after an AD drug fails? And does taking oral minoxidil in the morning…
- Blood, Sweat, and Hives · 19 minDr. Marc Serota makes the case for targeted lab testing in CSU—but the Derms worry it may open a can of worms. The Chronic Urticaria Index gets a closer look, shotgun allergy…
- Paging Dr. Telederm · 38 min · Řada 4 Epizoda 81After 70,000 virtual consults, Dr. Joe English knows what a photo can—and can’t—tell you. He joins the Derms to talk diagnostic curveballs, hospital saves, and bringing…
- Tregs, Tape, and Tresses · 29 min · Řada 4 Epizoda 80Three papers, three very different reactions: a Treg-boosting AD drug that may be too clever for its own good, a Steri-Strip trick you can use tomorrow, and Rinvoq alopecia data…
- Don’t Wait for the Tunnels · 18 minConvince the Derms on Drugs makes its debut with Dr. Christopher Sayed making the case for earlier systemic treatment in HS. Can he convince the Derms to act before recurring…
- Patch Me If You Can · 30 min · Řada 4 Epizoda 79Patch first or treat first? The Hamann brothers join the Derms to tackle mystery dermatitis, questionable allergens, wet wraps, hand eczema—and why the answer may be hiding in…
- The Clot Thickens · 34 min · Řada 4 Epizoda 78Three papers, three plot twists: new HS data that underwhelm on paper, a transected melanoma that may not need a sentinel node, and a possible explanation for why JAK clot risk…
- The Long and Short of Male Genital Disease · 42 minMale genital disease expert Dr. Christopher Bunker joins the Derms for the penis episode no one else was brave enough to make. Lichen sclerosus, circumcision, penile cancer—and…
- Three Sheets to Tofa · 33 min · Řada 3 Epizoda 76The Derms debut a shorter format with three papers and one newly dirt-cheap drug: generic tofacitinib. The safety, the risks, and the practicalities—right down to getting it for…
- Creams, Screams, and Measles · 47 min · Řada 3 Epizoda 75Pediatric dermatology legend Dr. Sheila Fallon Friedlander joins the Derms to sort through the new topical “Goldilocks” problem, take the sting out of Dupixent injections, and…
- Can We Stop Referring CSU? · 27 min · Řada 3 Epizoda 74The CSU rulebook is getting a rewrite, and the Derms on Drugs crew has thoughts. Dr. Jason Hawkes joins the conversation to talk new guidelines, new therapies, and why it may be…
- The Gray Zone Strikes Again · 46 min · Řada 3 Epizoda 73This week, the DoD tackle studies that leave plenty of room for debate—from skin cancer treatment costs and melanoma risk to HS, alopecia areata, and the real-world decisions…
- Making Nails Sexy Again · 49 min · Řada 3 Epizoda 72The DOD tackle longitudinal melanonychia, retronychia, nail biopsies, and other everyday nail problems—with enough practical pearls to make you rethink your next nail patient.
